Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-FU/Levofolinic Acid-Based Regimen in Advanced Colorectal Cancer After First-Line Failure
ChiCTR2500100974Phase 4Recruiting
- Sponsor
- PLA Navy No. 971 Hospital
- Start
- Apr 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levoleucovorin and fluorouracil in colorectal cancer (CRC), sponsored by PLA Navy No. 971 Hospital. Primary endpoint: Objective response rate. Started Apr 2025; status: recruiting.
02
Drugs
levoleucovorinfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2500100974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100974.